T173. GABA AND GLUTAMATE IN PATIENTS WITH 22Q11.2 DELETION SYNDROME AND HEALTHY VOLUNTEERS AND THE RELATION WITH COGNITION: A RANDOMIZED DOUBLE-BLIND 7TESLA PHARMACOLOGICAL MRS STUDY

BACKGROUND: 22q11.2 deletion syndrome (22q11DS) is characterized by a microdeletion on the long arm of chromosome 22. The clinical phenotype of this syndrome is highly variable but symptoms include cognitive impairment, heart malformations, auto-immune problems and a high risk of developing a psycho...

Descripción completa

Detalles Bibliográficos
Autores principales: Vingerhoets, Claudia, Tse, Desmond, van Oudenaren, Mathilde, van Duin, Esther, Hernaus, Dennis, Ramaekers, Jan, Janssen, Jaap, McAlonan, Grainne, Bloemen, Oswald, van Amelsvoort, Therese
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888583/
http://dx.doi.org/10.1093/schbul/sby016.449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888583/
http://dx.doi.org/10.1093/schbul/sby016.449

Ejemplares similares